Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 895

Sort by

Sort Order Select

Journal Articles

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Manuel J. Feinauer, Stefan W. Schneider, Anna S. Berghoff, Jose Ramon Robador, Cedric Tehranian, Matthia A. Karreman, Varun Venkataramani, Gergely Solecki, Julia Katharina Grosch, Katharina Gunkel, Bogdana Kovalchuk, Frank Thomas Mayer, Manuel Fischer, Michael O. Breckwoldt, Maik Brune, Yannick Schwab, Wolfgang Wick, Alexander T. Bauer, Frank Winkler

Blood (2021) 137 (9): 1219–1232.

https://doi.org/10.1182/blood.2020005710

Published: 2021

Includes: Supplemental data

Journal Articles

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits I. Mulder, Floris T. M. Bosch, Annie M. Young, Andrea Marshall, Robert D. McBane, II, Tyler J. Zemla, Marc Carrier, Pieter Willem Kamphuisen, Patrick M. M. Bossuyt, Harry R. Büller, Jeffrey I. Weitz, Saskia Middeldorp, Nick van Es

Blood (2020) 136 (12): 1433–1441.

https://doi.org/10.1182/blood.2020005819

Published: 2020

Includes: Supplemental data

Journal Articles

Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?

Marc Carrier, Tzu-Fei Wang

Blood (2020) 136 (6): 669–673.

https://doi.org/10.1182/blood.2019004177

Published: 2020

Journal Articles

Acute treatment of venous thromboembolism

Cecilia Becattini, Giancarlo Agnelli

Blood (2020) 135 (5): 305–316.

https://doi.org/10.1182/blood.2019001881

Published: 2020

Journal Articles

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

Ambar Farooqui, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Cassie Bacher, Jeanine Walenga, PhD, Ahmed Kouta, Walter Jeske, PhD, Bruce Lewis, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 2446.

https://doi.org/10.1182/blood-2019-131825

Published: 2019

Journal Articles

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

Kristina Roche, Brian Harnett, MD, Leona Browne, Stephanie Young, PharmD, Rufaro S. Chitsike, MD

Blood (2019) 134 (Supplement_1): 2447.

https://doi.org/10.1182/blood-2019-129340

Published: 2019

Journal Articles

To Assess the Appropriateness of the Venous Thromboembolism (VTE) Prophylaxis Agent Used Based on the VTE Risk Stratification in Hospitalised Acutely Ill Medical Patients

Maitreyee Rai, MBBS, Jian Liang Tan, MD, Meghana Parsi, MD, Malvika Duphare, DO, Mylene S. Go, MD

Blood (2019) 134 (Supplement_1): 2444.

https://doi.org/10.1182/blood-2019-122402

Published: 2019

Journal Articles

Potential Overuse of Primary Thromboprophylaxis in Medical Inpatients at Low Risk of Venous Thromboembolism

Mia Djulbegovic, MD, Kevin Chen, MD, Soundari Sureshanand, MCA, Sarwat Chaudhry, MD

Blood (2019) 134 (Supplement_1): 3385.

https://doi.org/10.1182/blood-2019-131827

Published: 2019

Journal Articles

Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS

Eric Huselton, MD, Amanda F Cashen, MD, John F. DiPersio, MD PhD, Meagan Jacoby, MD, Iskra Pusic, MD, Rizwan Romee, MD PhD, Mark A. Schroeder, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD

Blood (2019) 134 (Supplement_1): 3915.

https://doi.org/10.1182/blood-2019-132065

Published: 2019

Journal Articles

Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails

Sariya Wongsaengsak, MD, Somedeb Ball, MD, Nuvneet Khandelwal, MD, Alay Tikue, MD, Arunee Motes, Nusrat Jahan, MD, Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD

Blood (2019) 134 (Supplement_1): 4962.

https://doi.org/10.1182/blood-2019-125473

Published: 2019

Journal Articles

Comparison of Two Different ELISA Methods for Heparin-Induced Thrombocytopenia (HIT) Screening on an Automated ELISA Platform

Tatsiana Mardovina, MD PhD, John G Chromczak, MLS(ASCP)cmSHcm, Paul W Riley, PhD MBA

Blood (2019) 134 (Supplement_1): 4935.

https://doi.org/10.1182/blood-2019-125293

Published: 2019

Journal Articles

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

Gillian E Mair, Sven Reid Olson, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 4966.

https://doi.org/10.1182/blood-2019-130823

Published: 2019

Journal Articles

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Marianne Sinn, Christiane Pollich, Hanno Riess, Sven Bischoff, Piet Habbel, Christian W Scholz, Ernst Spaeth-Schwalbe, Maike de Wit, Anja Jühling, Eike Wolter, Lilianna Wislocka, Dr. Klamroth

Blood (2019) 134 (Supplement_1): 4969.

https://doi.org/10.1182/blood-2019-128166

Published: 2019

Journal Articles

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Beverly Schaefer, MD, Adriane Hausfeld, Paul Steele, MD, Jan Martin, Sandra Brannon, Adam Lane, PhD, Lori Luchtman-Jones, MD

Blood (2019) 134 (Supplement_1): 4915.

https://doi.org/10.1182/blood-2019-123716

Published: 2019

Journal Articles

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

Gaetano Giuffrida, MD, Concetta Conticello, MD, Valeria Calafiore, Enrica Antonia Martino, MD, Silvia Giamporcaro, MD, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4972.

https://doi.org/10.1182/blood-2019-131015

Published: 2019

Journal Articles

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Salma Shivji, MDFRCPC, Philip Chiang, MBSc, Lana A Castellucci, MD FRCPC, MSc, Elianna Saidenberg, MD FRCPC

Blood (2019) 134 (Supplement_1): 4974.

https://doi.org/10.1182/blood-2019-128395

Published: 2019

Journal Articles

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Ismail Elalamy, MD PhD

Blood (2019) 134 (Supplement_1): 4979.

https://doi.org/10.1182/blood-2019-123031

Published: 2019

Journal Articles

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Mohammed Abdullah Alsheef, MD, Kamal Gazal, MD, Nahar Alenizi, MD, Khalid Qushmaq, MD, Mukhtar Alomar, PharmD, Ghaydaa Juma Kullab, MD, Abdul Rehman Z. Zaidi, MBBS

Blood (2019) 134 (Supplement_1): 4955.

https://doi.org/10.1182/blood-2019-130548

Published: 2019

Journal Articles

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 4958.

https://doi.org/10.1182/blood-2019-132042

Published: 2019

Journal Articles

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Haoxu Ouyang, MD PhD, Ratesh Khillan, Nyein Htway Yu, MBBS, MD, Mohan Preet, MD

Blood (2019) 134 (Supplement_1): 4927.

https://doi.org/10.1182/blood-2019-132283

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?

Acute treatment of venous thromboembolism

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

To Assess the Appropriateness of the Venous Thromboembolism (VTE) Prophylaxis Agent Used Based on the VTE Risk Stratification in Hospitalised Acutely Ill Medical Patients

Potential Overuse of Primary Thromboprophylaxis in Medical Inpatients at Low Risk of Venous Thromboembolism

Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS

Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails

Comparison of Two Different ELISA Methods for Heparin-Induced Thrombocytopenia (HIT) Screening on an Automated ELISA Platform

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only